Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma - A prospective randomized trial

Radiotherapy and Oncology

Volumn 88, Issue 2, 2008, Pages 211-216

  Singh, Niveditha B ^a   Lakier, Roy H ^a   Donde, Bernard ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Epidemic Kaposi sarcoma; Palliative therapy; Radiotherapy

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPOSI SARCOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SARCOMA, KAPOSI; SOUTH AFRICA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 49149120818     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.03.009     Document Type: Article

References (26)

1. In: Perez C.A., Brady L.W., Halperin E.C., and Schmidt-Ullrich R.K. (Eds). Principles and practice of radiation oncology. 4th ed. (2004), Lippincott Williams and Wilkins, Philadelphia 776-782
2. Nobler M.P., Leddy M.E., and Huh S.H. The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome. J Clin Oncol 5 (1987) 107-112
3. Piedbois P., Frikha H., Martin L., Levy E., Haddad E., and Le Bourgeois J.P. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 30 (1994) 1207-1211
4. Kirova Y.M., Belembaogo E., Frikha H., Haddad E., Calitchi E., Levy E., et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases. Radiother Oncol 46 (1998) 19-22
5. Berson A.M., Quivey J.M., Harris J.W., and Wara W.M. Radiation therapy for AIDS-related Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 19 (1990) 569-575
6. Geara F., Le Bourgeois J.P., Piedbois P., Pavlovitch J.M., and Mazeron J.J. Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 21 (1991) 1517-1522
7. Piccinno R., Caccialanza M., and Cusini M. Role of radiotherapy in the treatment of epidemic Kaposi's sarcoma: experience with sixty-five cases. J Am Acad dermatol 32 (1995) 1000-1003
8. Stelzer K.J., and Griffin T.W. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi sarcoma. Int J Radiat Oncol Biol Phys 27 (1993) 1057-1061
9. Le Bourgeois J.P., Frikha H., Piedbois P., Le Pechoux C., Martin L., and Haddad E. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 30 (1994) 263-266
10. Cooper J.S., and Fried P.R. Defining the role of radiation therapy in the management of epidemic Kaposi's sarcoma. Int. J. Radiat Oncol Biol. Phys. 13 (1987) 35-39
11. de Wit R., Smit W.G.J.M., Veenhof K.H.N., Bakker P.J.M., Oldenburger F., and Gonzalez D.G. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800cGy. Radiother Oncol 19 (1990) 131-136
12. Ghabrial R., Quivey J.M., Dunn Jr. J.P., and Char D.H. Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva. Arch Ophthalmol 110 (1992) 1423-1426
13. Harrison M., Harrington K.J., Tomlinson D.R., and Stewart S.W. Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol 46 (1998) 23-28
14. Krown S.E. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol 22 (2004) 399-402
15. Orem J., Otieno M.W., and Remick S.C. AIDS-associated cancer developing nations. Curr opin Oncol 16 (2004) 468-476
16. Mqoqi, N., Kellett, P, Madhoo, J, Sitas, F. Incidence of histologically diagnosed cancer in South Africa, 1996-1997. Johannesburg: National Cancer Registry of South Africa, National Health Laboratory Service; 2003, pp. 45-6.
17. Mqoqi N, Kellett P, Sitas F, Jula M. Incidence of histologically diagnosed cancer in South Africa, 1998-1999. Johannesburg: National Cancer Registry of South Africa, National Health Laboratory Service; 2004, pp. 31-3.
18. IAEA Tecdoc 1224. IAEA Vienna. 2001. pp. 15-24. Available from: http://www.-pub.iaea.org/MTCD/publications/PDF/te_1224_prn.pdf.
19. Krown S.E., Metroka C., and Wernz J.C. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7 (1989) 1201-1207
20. Lukawska J., Cottrill C., and Bower M. The changing role of radiotherapy in AIDS-related malignancies. Clin Oncol 15 (2003) 2-6
21. Stein M.E., Lakier R., Spencer D., Dale J., Kuten A., MacPhail P., et al. Radiation therapy for non AIDS-associated (Classic and Endemic). Int J Radiat Oncol Biol Phys 28 (1994) 613-619
22. Cooper J.S., and Fried P.R. Toxicity of oral radiotherapy in patients with acquired immunodeficiency syndrome. Arch Otolaryngol Head Neck Surg 113 (1987) 327-328
23. Watkins E.B., Findlay P., Gelmann M.D., Lane H.C., and Zabell A. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int J Radiat Oncology Biol Phys 13 (1987) 1403-1408
24. Kao G.D., Devine P., and Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients - acute response to radiation therapy. Arch Otolaryngol Head Neck Surg 125 (1999) 873-876
25. Chak L.Y., Gill P.S., Levine A.M., Meyer P.R., Anselmo J.A., and Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 6 (1988) 863-867
26. Gallafent J.H., Buskin S.E., De Turk P.B., and Aboulafia D.M. Profile of patients with Kaposi sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 23 (2005) 1253-1260